-
- 抗原 See all TNFSF15 抗体
- TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
-
抗原表位
- AA 155-183, Middle Region
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This TNFSF15 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
- 特异性
- This antibody detects TNFSF15 (Center).
- 交叉反应 （详细）
- Species reactivity (tested):Human
- 纯化方法
- Protein A column followed by peptide affinity purification
- 免疫原
- KLH conjugated synthetic peptide between 155-183 amino acids from the Central region of human TNFSF15
- 亚型
- Ig Fraction
- Top Product
- Discover our top product TNFSF15 Primary Antibody
-
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) (AA 161-251) antibody
TNFSF15 适用: 人, 小鼠 WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) antibodyTNFSF15 适用: 人 IHC, StM 宿主: 兔 Monoclonal VEGI-2052R unconjugated Recombinant Antibody
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) antibodyTNFSF15 适用: 人 IHC, StM 宿主: 小鼠 Monoclonal rVEGI-1283 unconjugated Recombinant Antibody
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) antibodyTNFSF15 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) antibodyTNFSF15 适用: 人 IHC, StM 宿主: 小鼠 Monoclonal VEGI-1283 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) antibodyTNFSF15 适用: 人 IHC (p) 宿主: 兔 Monoclonal VEGI-2052R unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) antibodyTNFSF15 适用: 人 IHC (p) 宿主: 兔 Monoclonal VEGI-2052R unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) (C-Term) antibodyTNFSF15 适用: 人 WB, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) (AA 72-251) antibodyTNFSF15 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) (C-Term) antibodyTNFSF15 适用: 人, 小鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.25 mg/mL
- 缓冲液
- PBS with 0.09 % (W/V) sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
- 抗原
- TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
- 别名
- TNFSF15 (TNFSF15 产品)
- 别名
- TTPAL antibody, TL1 antibody, TL1A antibody, VEGI antibody, VEGI192A antibody, Tl1 antibody, Tl1a antibody, Vegi antibody, tumor necrosis factor superfamily member 15 antibody, TNF superfamily member 15 antibody, tumor necrosis factor (ligand) superfamily, member 15 antibody, TNFSF15 antibody, Tnfsf15 antibody
- 背景
- The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. An additional isoform encoded by an alternatively spliced transcript variant has been reported but the sequence of this transcript has not been determined.Synonyms: TL1, TL1A, TNF ligand-related molecule 1, Tumor necrosis factor ligand superfamily member 15, VEGI, Vascular endothelial cell growth inhibitor
- 基因ID
- 9966
- NCBI登录号
- NP_001191273
- 途径
- Positive Regulation of Endopeptidase Activity, Autophagy
-
You are here:
